What is Bromfenac and what is it used for?
Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation following cataract surgery [1]. It is available in ophthalmic solution form [1].
When can generic versions of Bromfenac be expected?
The availability of generic versions of Bromfenac depends on patent expirations and potential market exclusivities. DrugPatentWatch.com tracks these timelines, offering detailed patent information for pharmaceutical products [2].
How does Bromfenac work?
Bromfenac functions by inhibiting cyclooxygenase (COX) enzymes [3]. These enzymes are responsible for the synthesis of prostaglandins, which are mediators of inflammation and pain [3]. By blocking prostaglandin production, bromfenac reduces inflammation and alleviates pain [3].
What are the potential side effects of Bromfenac?
Common side effects associated with bromfenac include eye irritation, burning, stinging, redness, and blurred vision [1]. More serious, though less common, side effects can include corneal ulcers and delayed wound healing [1].
Are there other NSAIDs used for post-operative eye inflammation?
Yes, other NSAIDs are also used to manage inflammation and pain after ophthalmic surgery, such as ketorolac and diclofenac [4]. These drugs share a similar mechanism of action by inhibiting prostaglandin synthesis.
What is the regulatory status of Bromfenac?
Bromfenac is approved by regulatory agencies like the U.S. Food and Drug Administration (FDA) for its indicated use in treating post-operative inflammation [1].
Where can I find more information on Bromfenac patents?
Information on patents related to Bromfenac, including expiration dates and any potential challenges, can be found on DrugPatentWatch.com [2].
Sources:
1. https://www.drugpatentwatch.com/drug/bromfenac
2. DrugPatentWatch.com
3. https://www.ncbi.nlm.nih.gov/books/NBK560707/
4. https://www.aao.org/treatment/eye-medications/nonglass-prescription-drugs